Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Dallas, Texas--(Newsfile Corp. - October 2, 2024) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners initiates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL)

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Advancing proprietary, synthetic first and best-in-class cannabinoid and psychedelic-assisted therapeutics
• Conducting FDA phase 2/3 trial, IHL-42X, for the treatment of Obstructive Sleep Apnea (OSA)
• IHL-42X pivotal phase 2 top-line data expected first half 2025

Click image above to view full announcement.

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/225397

You May Also Be Interested In

• J Capital Research cautious on Microchip: 'riding high on AI hype but looks weak'
• 5.5 magnitude earthquake strikes Northern California - EMSC
• Doncasters IPO sees demand for 30 times available shares